EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Editorial

Daily consensus interferon (CIFN) monotherapy in non-responders or relapsers to a previous interferon regime: One year follow-up after 48 weeks of treatment

Murat ALADAĞ ¹ , Zeki KARASU ² , Harlan WRIGHT ³ , Ahmet GÜRAKAR ⁴

Author Affiliation(s)

1.

İnönü Üniversitesi Tıp Fakültesi, Gastroenteroloji Bilim Dalı ve İç Hastalıkları Anabilim Dalı, Malatya

2.

Ege Üniversitesi Tıp Fakültesi Gastroenteroloji Bilim Dalı, İzmir

3.

Integris Baptist Medical Center, Nazih Zuhdi Transplant Institute, Oklahoma City, USA

4.

Division of Liver Transplantation Medicine/Hepatology, Nazih Zuhdi Transplantation Institute, Integris Baptist Medical Center, Oklahoma City, OK.

Turk J Gastroenterol 2006; 17: 35-39

Keywords : Chronic hepatitis C, daily consensus interferon, sustained virologic response

Read: 1593 Downloads: 1283 Published: 25 July 2019

Volume 17, Issue 1, March 2006

Previous Article

Files